Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study

European Journal of Cancer

Volumn 54, Issue , 2016, Pages 131-138

  Ribal, Maria J ^a   Mengual, Lourdes ^a   Lozano, Juan J ^b   Ingelmo Torres, Mercedes ^a   Palou, Joan ^c   Rodríguez Faba, Oscar ^c   Witjes, Johannes A ^d   Van Der Heijden, Antoine G ^d   Medina, Rafael ^e   Conde, Jose M ^e   Marberger, Michael ^f   Schmidbauer, Joerg ^f   Fernández, Pedro L ^a   Alcaraz, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c FUNDACIÓ PUIGVERT   (Spain)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biomarkers; Bladder cancer; Gene expression; Molecular test; Non invasive diagnosis; Sensitivity and specificity; Urine

Indexed keywords

TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; CLINICAL TRIAL; EUROPE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVER VARIATION; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; URINALYSIS; URINE; VALIDATION STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; EUROPE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OBSERVER VARIATION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; URINALYSIS; URINARY BLADDER NEOPLASMS;

EID: 84952772306     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.11.003     Document Type: Article

References (26)

1. M. Babjuk, M. Burger, R. Zigeuner, and et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013 Eur Urol 64 4 2013 639 653
2. A.C. Goh, and S.P. Lerner Application of new technology in bladder cancer diagnosis and treatment World J Urol 27 3 2009 301 307
3. Z.L. Smith, and T.J. Guzzo Urinary markers for bladder cancer F1000Prime Rep 5 21 2013
4. G. Mowatt, S. Zhu, M. Kilonzo, and et al. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer Health Technol Assess 14 4 2010 i iv
5. G. Gakis, S. Kruck, and A. Stenzl Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers? Curr Opin Urol 20 5 2010 388 392
6. D. Tilki, M. Burger, G. Dalbagni, and et al. Urine markers for detection and surveillance of non-muscle-invasive bladder cancer Eur Urol 60 3 2011 484 492
7. J.A. Witjes, E. Comperat, N.C. Cowan, and et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines Eur Urol 65 4 2014 778 792
8. L. Mengual, M.J. Ribal, J.J. Lozano, and et al. Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models J Urol 191 1 2014 261 269
9. P.M. Bossuyt, J.B. Reitsma, D.E. Bruns, and et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. The Standards for Reporting of Diagnostic Accuracy Group Croat Med J 44 5 2003 639 650
10. L. Mengual, M. Burset, M. Marin-Aguilera, M.J. Ribal, and A. Alcaraz Multiplex preamplification of specific cDNA targets prior to gene expression analysis by TaqMan Arrays BMC Res Notes 1 1 2008 21
11. L. Mengual, M. Burset, M.J. Ribal, and et al. Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma Clin Cancer Res 16 9 2010 2624 2633
12. X. Robin, N. Turck, A. Hainard, and et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves BMC Bioinformatics 12 77 2011
13. A. Lopez-Beltran, G. Sauter, T. Gasser, and et al. Tumours of the urinary system J.N. Eble, G. Sauter, J.I. Epstein, I.A. Sesterhenn, Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organization classification of tumours 2004 IARC Press Lyon 89 157
14. L.H. Sobin, M. Gospodariwicz, and C.H. Wittekind TNM classification of malignant tumours. UICC International Union Against Cancer ed. 7 2009 Wiley-Blackwell New York
15. M. Musquera, L. Mengual, and M.J. Ribal Non-invasive diagnosis bladder cancer: new molecular markers and future perspectives Arch Esp Urol 66 5 2013 487 494
16. L. Cheng, S. Zhang, G.T. MacLennan, S.R. Williamson, A. Lopez-Beltran, and R. Montironi Bladder cancer: translating molecular genetic insights into clinical practice Hum Pathol 42 4 2011 455 481
17. P.J. Goebell, and M.A. Knowles Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium Urol Oncol 28 4 2010 409 428
18. P. O'Sullivan, K. Sharples, M. Dalphin, and et al. A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria J Urol 188 3 2012 741 747
19. A. Holyoake, P. O'Sullivan, R. Pollock, and et al. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder Clin Cancer Res 14 3 2008 742 749
20. Y. Lotan, and C.G. Roehrborn Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses Urology 61 1 2003 109 118
21. M.S. Soloway, M. Sofer, and A. Vaidya Contemporary management of stage T1 transitional cell carcinoma of the bladder J Urol 167 4 2002 1573 1583
22. V. Soukup, M. Babjuk, J. Bellmunt, and et al. Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature Eur Urol 62 2 2012 290 302
23. P.I. Karakiewicz, S. Benayoun, C. Zippe, and et al. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder BJU Int 97 5 2006 997 1001
24. B. Laxman, D.S. Morris, J. Yu, and et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer Cancer Res 68 3 2008 645 659
25. T. Jamaspishvili, M. Kral, I. Khomeriki, and et al. Quadriplex model enhances urine-based detection of prostate cancer Prostate Cancer Prostatic Dis 14 4 2011 354 360
26. Y. Lotan, S.F. Shariat, B.J. Schmitz-Drager, and et al. Considerations on implementing diagnostic markers into clinical decision making in bladder cancer Urol Oncol 28 4 2010 441 448